3 documents found, page 1 of 1
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabol...
Afonso, Marta B.; Islam, Tawhidul; Magusto, Julie; Amorim, Ricardo; Lenoir, Véronique; Simões, Rui F.; Teixeira, José; Silva, Liana C.Background and Aims: Receptor‐interacting protein kinase 3 (RIPK3) mediates NAFLD progression, but its metabolic function is unclear. Here, we aimed to investigate the role of RIPK3 in modulating mitochondria function, coupled with lipid droplet (LD) architecture in NAFLD. Approach and Results: Functional studies evaluating mitochondria and LD biology were performed in wild‐type (WT) and Ripk3−/− mice fed a cho...
Targeting liver cell metabolism and function in non-alcoholic fatty liver disease
Islam, TawhidulNon-alcoholic fatty liver disease (NAFLD) comprises a series of liver lesions ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) and is a major cause of chronic liver disease that may progress to cirrhosis and hepatocellular carcinoma. Despite the risk factors related with the metabolic syndrome, the mechanisms of disease are not entirely known. Further, several promising molecules with diffe...
Inhibition of receptor-interacting protein kinase 1 improves experimental non-a...
Majdi, Amine; Aoudjehane, Lynda; Ratziu, Vlad; Islam, Tawhidul; Afonso, Marta B; Conti, Filomena; Mestiri, Taïeb; Lagouge, Marie; Foufelle, FabienneIn non-alcoholic fatty liver disease (NAFLD), hepatocytes can undergo necroptosis: a regulated form of necrotic cell death mediated by the receptor-interacting protein kinase (RIPK) 1. Herein, we assessed the potential for RIPK1 and its downstream effector mixed lineage kinase domain-like protein (MLKL) to act as therapeutic targets and markers of activity in NAFLD.